Reaction
Lymph Node Tuberculosis reporting signals
As of the last recalculation, Lymph Node Tuberculosis appears in 734 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is PYRAZINAMIDE (PRR 144.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pyrazinamide | 45 | 144.7 | 145.4 |
| Isoniazid | 60 | 114.3 | 114.7 |
| Rifampicin | 32 | 93.7 | 94.0 |
| Efavirenz | 26 | 68.5 | 68.7 |
| Rifampin | 21 | 42.0 | 42.0 |
| Baricitinib | 11 | 32.8 | 32.9 |
| Lamivudine | 33 | 31.7 | 31.7 |
| Infliximab | 179 | 30.4 | 30.4 |
| Zidovudine | 13 | 28.0 | 28.1 |
| Lamivudine Oral | 23 | 26.6 | 26.6 |
| Adalimumab-Fkjp | 34 | 21.8 | 21.8 |
| Adalimumab-Aaty | 34 | 21.3 | 21.3 |
| Lopinavir And Ritonavir | 9 | 19.1 | 19.1 |
| Busulfan | 8 | 14.6 | 14.6 |